Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen
Public ClinicalTrials.gov record NCT00135382. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that virologically controlled HIV-infected individuals can successfully switch from a protease inhibitor (PI)-based regimen to an efavirenz-based regimen while maintaining virologic control, as evaluated by the proportion of subjects who continue to have plasma HIV-1 levels \< 50 copies/mL. In addition, a simplified once-daily regimen will improve adherence and quality of life.
Study identification
- NCT ID
- NCT00135382
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 254 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2002 (Type not available)
- Primary completion
- Oct 2005 (Actual)
- Completion
- Oct 2005 (Actual)
- Last update posted
- Feb 17, 2010
2002 – 2005
United States locations
- U.S. sites
- 46
- U.S. states
- 17
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Beverly Hills | California | — | — |
| Local Institution | Fountain Valley | California | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Los Angeles | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | San Francisco | California | — | — |
| Local Institution | Tarzana | California | — | — |
| Local Institution | West Hollywood | California | — | — |
| Local Institution | Denver | Colorado | — | — |
| Local Institution | Norwalk | Connecticut | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Atlantis | Florida | — | — |
| Local Institution | Daytona Beach | Florida | — | — |
| Local Institution | Fort Lauderdale | Florida | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Miami | Florida | — | — |
| Local Institution | Miami Beach | Florida | — | — |
| Local Institution | North Miami | Florida | — | — |
| Local Institution | Orlando | Florida | — | — |
| Local Institution | Plantation | Florida | — | — |
| Local Institution | Safety Harbor | Florida | — | — |
| Local Institution | South Miami | Florida | — | — |
| Local Institution | Tampa | Florida | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Decatur | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Springfield | Massachusetts | — | — |
| Local Institution | Kansas City | Missouri | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | East Orange | New Jersey | — | — |
| Local Institution | Newark | New Jersey | — | — |
| Local Institution | Union | New Jersey | — | — |
| Local Institution | Brooklyn | New York | — | — |
| Local Institution | Manhasset | New York | — | — |
| Local Institution | Mount Vernon | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Stony Brook | New York | — | — |
| Local Institution | Valhalla | New York | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Columbia | South Carolina | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Hampton | Virginia | — | — |
| Local Institution | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00135382, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2010 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00135382 live on ClinicalTrials.gov.